Iceland· IS-EU/1/14/931/01-02
Mekinist
A trametinib product containing trametinibum inn, registered in Iceland by Novartis Europharm Limited*. The same ATC class is registered in 12 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Trametinib is registered in 12 of 19 countries.
Countries holding a registration under ATC L01EE01 (trametinib), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Trametinib · ATC L01EE01
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of trametinib costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Trametinib · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$215.55
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Trametinibum INN
- Manufacturer
- Novartis Europharm Limited*
- Country
- Iceland (IS)
- ATC code
- L01EE01
- ATC class
- Trametinib
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean37419430 stk x1 glasISK 271472
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for trametinib.
Graded by severity as the source publishes them — 22 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Trametinib · interactions on record
22 records
- 22 moderate
Most severe, free to view
- FostamatinibB02BX09moderate
- ElagolixH01CC03moderate
- SarecyclineJ01AA14moderate
- IsavuconazoleJ02AC05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Trametinib in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandMekinist 0.5 mg, FilmtablettenNovartis Pharma Schweiz AG
- SpainMEKINIST 0,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULANovartis Europharm Limited
- IrelandMekinist 0.5 mg film-coated tabletsNovartis Europharm Limited
- NetherlandsMekinist 0,5 mg filmomhulde tabletNovartis Europharm Limited
- NorwayMekinistNovartis Europharm Limited (1)
- PolandMekinistNovartis Europharm Limited
- SwedenMekinist 0,5 mg Filmdragerad tablettNovartis Europharm Limited
- United KingdomMekinist 0.5mg tabletsOriginalis B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Mekinist, Spexotras
- Norway · Mekinist, Spexotras
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9a70df6b-20dc-48e6-bff7-77987ae5122b GET /v1/drugs/9a70df6b-20dc-48e6-bff7-77987ae5122b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "L01EE01",
"marketed": true,
"strength": "0,5 mg",
"ma_number": "EU/1/14/931/01-02",
"substance": "Trametinibum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í krabbameinslækningum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "41820"
}See everything about trametinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.